Clinical Trial Update: The Effect of n-3 Polyunsaturated Fatty Acid Supplements in Patients With Non-alcoholic Fatty Liver Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the effect of omega-3 fatty acid supplements in patients with non-alcoholic fatty liver disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• Omega-3 fatty acids (n-3 polyunsaturated fatty acids) supplements (n-3 polyunsaturated fatty acids)

Snippet

Sponsor: University of Nottingham | Conditions: Non-alcoholic Fatty Liver Disease | Phase 2 | Status: COMPLETED